---
schema_version: "secwatch.filing_event.v1"
accession: "0001062993-25-012767"
form_type: "8-K"
ticker: "MDCX"
cik: "0001997296"
company_name: "Medicus Pharma Ltd."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:46:48.225700+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Medicus Pharma enters warrant inducement for $3.75M gross; also sells $1.52M shares via SEPA

## Summary
- Holder exercises 1.34M existing warrants at $2.80; receives 2.68M new warrants at $3.75 expiring in 5 years.
- Gross proceeds from warrant exercise ~$3.75M; net used for clinical trials, working capital, and Antev acquisition costs.
- Company sold 490,000 common shares to Yorkville via SEPA for net proceeds of ~$1.52M at ~$3.10/share.
- Maxim Group LLC receives 6.0% cash fee on warrant exercise gross proceeds.
- Company to file S-1 registration for resale of new warrant shares within 120 days.

## SEC filing metadata
- accession: 0001062993-25-012767
- form_type: 8-K
- ticker: MDCX
- cik: 0001997296
- company_name: Medicus Pharma Ltd.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1997296/000106299325012767/0001062993-25-012767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1997296/000106299325012767/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062993-25-012767
- JSON: https://secwatch.observer/filing/0001062993-25-012767.json
- Plain text: https://secwatch.observer/filing/0001062993-25-012767.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
